Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
CGEM
Cullinan Therapeutics, Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$15.35
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$987.84M
Country
USA
RECENT INSIDER TRADES
2026-09-10
· Michaelson Jennifer
(Chief Scientific Officer)
· SELL
2026-09-10
· Michaelson Jennifer
(Chief Scientific Officer)
· OTHER
2026-08-14
· Michaelson Jennifer
(Chief Scientific Officer)
· SELL
2026-08-14
· Michaelson Jennifer
(Chief Scientific Officer)
· OTHER
2026-07-07
· Michaelson Jennifer
(Chief Scientific Officer)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
199
Shares held
81,242,933
Value
$1.37B
Percent of shares outstanding
126.24%
As of quarter end
2026-06-30
RECENT NEWS
Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia
Cullinan Therapeutics: Compelling Pullback For CLN-978's Potential In Autoimmune Diseases
Cullinan Therapeutics at stifel 2026 forum: autoimmune pipeline advances
Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio
Cullinan Therapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Cullinan Therapeutics, Inc. (CGEM) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit